followed by a stem cell transplant
may halt the progression of
multiple sclerosis (MS), a study in
the Lancet has suggested.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 14 Jun 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 16
AUSTRALIAN Pharmaceutical Industries (API) has unveiled plans for the ongoing development of its Priceline Pharmacy network, including a trial of “click and collect” shopping in 2019 and a major upgrade of its Sister Club loyalty platform.